Li Na, Jia Jia, Wu Xingmao, Zhao Yang, Zang Bin
Department of Critical Care Medicine, Shengjing Hospital Affiliated to China Medical University, Shenyang 110004, Liaoning, China. Corresponding author: Zang Bin, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Nov;30(11):1071-1076. doi: 10.3760/cma.j.issn.2095-4352.2018.011.012.
To investigate the regulative effect of hemichannels protein Pannexin-1 on P2X7 receptor activation and caspase-1 mediated inflammatory response in the lungs of mice with lung injury.
Sixty male C57BL/6 mice were randomly divided into five groups with 12 mice in each group: sham operation group (Sham group), mechanical ventilation (MV) group, MV + low dose lipopolysaccharide (LPS) group (MLL group), MV + medium and high dose LPS group (MML group) and MV + high dose LPS group (MHL group). A "two-hit" lung injury model was reproduced by MV with high tidal volume combined with LPS injection in airway. All the mice underwent tracheotomy and intubation. After operation, the mice in Sham group were maintained spontaneous breathing, and those in other four groups were put on small animal ventilators to give MV with a large tidal volume of 28 mL/kg. After stable respiration in mice, those in the Sham group and MV group were injected 8 mL/kg of normal saline (NS) into the airway, and those in MLL, MML and MHL groups were given 2, 5 and 8 mg/kg of LPS respectively (diluted with NS into 8 mL/kg). After 4 hours on MV, the mice were sacrificed, and bronchoalveolar lavage fluid (BALF) was extracted to determine intracellular and extracellular ATP concentration. Lung tissue was harvested and water containing ratio of lungs was measured. The degree of lung pathological damage was observed after hematoxylin-eosin (HE) staining, and lung injury score was calculated. The expression of Pannexin-1 protein in lung tissue was calculated with immunohistochemistry. Western Blot and fluorescence quantitative reverse transcription-polymerase chain reaction (RT-qPCR) were used to detect the protein and mRNA expressions of Pannexin-1, P2X7 receptor, caspase-1 and interleukin-1β (IL-1β).
There was no obvious pathological change in lung tissue in Sham group, intracellular ATP concentration was higher than extracellular ATP concentration, water content in lung tissue was lower, Pannexin-1 expression was low in lung tissue by immunohistochemical staining, and Pannexin-1, P2X7 receptor, caspase-1 and IL-1β were only expressed in micro-protein and mRNA in lung tissue. Compared with the Sham group, the alveolar lesions and hemorrhages in the MV group were not obvious, and lung injury score was slightly increased. There was no significant fluctuation between intracellular ATP concentration and extracellular ATP concentration. The water content in lung tissue was increased significantly, while the expressions of Pannexin-1, P2X7 receptor, caspase-1 and IL-1β in lung tissue were increased slightly. After LPS intervention, progressively increased lung exudation, ruptured alveoli, dilated capillaries, and inflammatory cells were found, and lung injury score was increased without significant difference among the three LPS doses groups. With the increase in LPS dosage, the concentration of extracellular ATP in BALF was increased, the concentration of intracellular ATP was decreased, the water containing ratio of lung tissue was increased gradually, and the protein and mRNA expressions of Pannexin-1, P2X7 receptor, caspase-1 and IL-1β in lung tissue were increased gradually in a dose-dependent manner. The parameters in MHL group showed significant differences as compared with those in MV group [lung injury score: 8.25±0.45 vs. 3.50±0.52; intracellular ATP concentration (μmol/L): 198.76±150.77 vs. 896.69±281.11, extracellular ATP concentration (μmol/L): 336.57±90.28 vs. 141.52±42.22; lung water containing rate: (6.37±0.11)% vs. (5.05±0.14)%; Pannexin-1 protein (gray value): 3.20±0.70 vs. 1.54±0.76, Pannexin-1 mRNA (2): 7.86±0.86 vs. 2.47±0.92; P2X7 receptor protein (gray value): 3.18±0.88 vs. 1.80±0.72, P2X7 receptor mRNA (2): 7.17±0.96 vs. 2.31±0.45; caspase-1 protein (gray value): 3.00±0.45 vs. 0.93±0.51, caspase-1 mRNA (2): 4.39±0.91 vs. 2.74±0.41; IL-1β protein (gray value): 2.54±1.08 vs. 1.16±0.53, IL-1β mRNA (2): 132.34±41.48 vs. 19.67±8.67; all P < 0.05].
Pannexin-1 may be involved in LPS and MV induced lung injury, which may be regulated by intracellular release of ATP to the extracellular site and binding to P2X7 receptor on the cell surface, thereby regulating active caspase-1 production and release, involving in the production of IL-1β and other inflammatory factors eventually which leads to the occurrence and development of lung injury.
探讨半通道蛋白Pannexin-1对肺损伤小鼠肺组织中P2X7受体激活及半胱天冬酶-1介导的炎症反应的调节作用。
将60只雄性C57BL/6小鼠随机分为5组,每组12只:假手术组(Sham组)、机械通气(MV)组、MV+低剂量脂多糖(LPS)组(MLL组)、MV+中高剂量LPS组(MML组)和MV+高剂量LPS组(MHL组)。采用大潮气量机械通气联合气道内注射LPS的方法复制“二次打击”肺损伤模型。所有小鼠均行气管切开及插管术。术后,Sham组小鼠维持自主呼吸,其他4组小鼠置于小动物呼吸机上给予28 mL/kg大潮气量机械通气。待小鼠呼吸稳定后,Sham组和MV组小鼠气道内注射8 mL/kg生理盐水(NS),MLL、MML和MHL组小鼠分别给予2、5和8 mg/kg LPS(用NS稀释至8 mL/kg)。机械通气4小时后,处死小鼠,提取支气管肺泡灌洗液(BALF)测定细胞内和细胞外ATP浓度。取肺组织,测量肺组织含水量。苏木精-伊红(HE)染色后观察肺组织病理损伤程度,计算肺损伤评分。采用免疫组织化学法检测肺组织中Pannexin-1蛋白表达。采用蛋白质免疫印迹法(Western Blot)和荧光定量逆转录-聚合酶链反应(RT-qPCR)检测Pannexin-1、P2X7受体、半胱天冬酶-1和白细胞介素-1β(IL-1β)的蛋白及mRNA表达。
Sham组肺组织无明显病理改变,细胞内ATP浓度高于细胞外ATP浓度,肺组织含水量较低,免疫组织化学染色显示肺组织中Pannexin-1表达较低,肺组织中Pannexin-1、P2X7受体、半胱天冬酶-1和IL-1β仅在微量蛋白和mRNA水平表达。与Sham组相比,MV组肺泡病变及出血不明显,肺损伤评分略有增加。细胞内ATP浓度与细胞外ATP浓度之间无明显波动。肺组织含水量显著增加,而肺组织中Pannexin-1、P2X7受体、半胱天冬酶-1和IL-1β的表达略有增加。LPS干预后,肺组织渗出逐渐增加,肺泡破裂,毛细血管扩张,可见炎性细胞,肺损伤评分增加,3个LPS剂量组之间差异无统计学意义。随着LPS剂量增加,BALF中细胞外ATP浓度升高,细胞内ATP浓度降低,肺组织含水量逐渐增加,肺组织中Pannexin-1、P2X7受体、半胱天冬酶-1和IL-1β的蛋白及mRNA表达呈剂量依赖性逐渐增加。MHL组与MV组相比,各项指标差异有统计学意义[肺损伤评分:8.25±0.45比3.50±0.52;细胞内ATP浓度(μmol/L):198.76±150.77比896.69±281.11,细胞外ATP浓度(μmol/L):336.57±90.28比141.52±42.22;肺含水量:(6.37±0.11)%比(5.05±0.14)%;Pannexin-1蛋白(灰度值):3.20±0.70比1.54±0.76,Pannexin-1 mRNA(2-ΔΔCt):7.86±0.86比2.47±0.92;P2X7受体蛋白(灰度值):3.18±0.88比1.80±0.72,P2X7受体mRNA(2-ΔΔCt):7.17±0.96比2.31±0.45;半胱天冬酶-1蛋白(灰度值):3.00±0.45比0.93±0.51,半胱天冬酶-1 mRNA(2-ΔΔCt):4.39±0.91比2.74±0.41;IL-1β蛋白(灰度值):2.54±1.08比1.16±0.53,IL-1β mRNA(2-ΔΔCt):132.34±41.48比19.67±8.67;均P<0.05]。
Pannexin-1可能参与LPS和机械通气诱导的肺损伤,其机制可能是通过细胞内ATP释放到细胞外并与细胞表面P2X7受体结合,从而调节活性半胱天冬酶-1的产生和释放,最终参与IL-1β等炎症因子的产生,导致肺损伤的发生和发展。